Spectrumedics Medical (hereinafter "Spectrumedics") is pleased to announce that its Sonico-CX Intravascular Lithotripsy (IVL) System ...

Spectrumedics joins J&J MedTech’s Shockwave and Elixir Medical as the only other companies with EU-approved IVL systems.

Olympus announced it signed a definitive agreement to acquire lithotripsy system design and production technology from Cybersonics, Inc. With Olympus a technology provider designing innovative ...

LithiX™ HC-IVL is a novel lithotripsy system designed to facilitate treatment of heart disease exacerbated by the presence of calcium within coronary artery plaques MY-IVL study enrolled 102 real ...

Coronary Artery Disease (CAD) is the most common heart disease and most frequent cause of death in the U.S., with over 20 million adults affected by this condition Abbott's investigational Coronary ...

The demand for lithotripsy procedures is expected to increase in the coming years. This expected increase is supported by a review of the Global Lithotripsy Devices Market. It is forecasted to grow at ...

PARIS--(BUSINESS WIRE)--Elixir Medical, a developer of transformative technologies to treat cardiovascular and peripheral disease, today announced that the PINNACLE I study evaluating the safety and ...

Please provide your email address to receive an email when new articles are posted on . In the Disrupt BTK pilot study, intravascular lithotripsy successfully treated calcified and stenotic ...

Sonico-CX provides a safe and effective option for treating calcified coronary lesions.SINGAPORE, Jan. 6, 2026 /PRNewswire/ -- Spectrumedics Medical (hereinafter "Spectrumedics") is pleased ...